Agios Pharmaceuticals
AGIO
#4802
Rank
A$3.06 B
Marketcap
A$51.55
Share price
-3.51%
Change (1 day)
-14.80%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: A$3.06 Billion

As of July 2026 Agios Pharmaceuticals has a market cap of A$3.06 Billion. This makes Agios Pharmaceuticals the world's 4802th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.06 B25.68%
2025A$2.43 B-20.34%
2024A$3.06 B67.62%
2023A$1.82 B-19.42%
2022A$2.26 B-7.92%
2021A$2.46 B-36.91%
2020A$3.90 B-16.34%
2019A$4.66 B22.42%
2018A$3.81 B6.73%
2017A$3.57 B46.78%
2016A$2.43 B-27.6%
2015A$3.35 B-33.86%
2014A$5.07 B506.25%
2013A$0.83 B

End of Day market cap according to different sources

On Jul 21st, 2026 the market cap of Agios Pharmaceuticals was reported to be:

A$3.17 Billion
by Nasdaq info icon info icon
A$3.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$202.28 B 6,498.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.483 T 48,273.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$145.37 B 4,641.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
A$2.06 B-32.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$19.76 B 544.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$16.14 B 426.50%๐Ÿ‡บ๐Ÿ‡ธ USA